Pantoprazole Tablet, Delayed Release
NDC Package 55111-333-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Pantoprazole tablets is pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). This formulation utilizes a tablet, delayed release delivery system. Marketed by Dr.reddy's Laboratories Limited, this product is identified by NDC 55111-333 and is authorized under FDA application ANDA077619.

Identification & Billing

NDC Package Code
55111-333-01
Package Description
100 TABLET, DELAYED RELEASE in 1 BOTTLE
Product Code
55111-333
11-Digit Billing Format
55111033301
RxNorm Crosswalk
  • RxCUI: 251872 - pantoprazole sodium 20 MG Delayed Release Oral Tablet
  • RxCUI: 251872 - pantoprazole 20 MG Delayed Release Oral Tablet
  • RxCUI: 251872 - pantoprazole 20 MG (as pantoprazole sodium sesquihydrate 22.56 MG) Delayed Release Oral Tablet
  • RxCUI: 314200 - pantoprazole sodium 40 MG Delayed Release Oral Tablet
  • RxCUI: 314200 - pantoprazole 40 MG Delayed Release Oral Tablet

Clinical Specifications

Proprietary Name
Pantoprazole
Non-Proprietary Name
Pantoprazole
Substance Name
Pantoprazole Sodium
Dosage Form
Tablet, Delayed Release - A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
Dr.reddy's Laboratories Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA077619
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-19-2011
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (55111-333). Click a package code to view its specific billing and regulatory data.

55111-333-05
500 TABLET, DELAYED RELEASE in 1 BOTTLE
55111-333-10
1000 TABLET, DELAYED RELEASE in 1 BOTTLE
55111-333-30
30 TABLET, DELAYED RELEASE in 1 BOTTLE
55111-333-78
10 BLISTER PACK in 1 CARTON / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (55111-333-79)
55111-333-81
3 BLISTER PACK in 1 CARTON / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (55111-333-79)
55111-333-90
90 TABLET, DELAYED RELEASE in 1 BOTTLE
55111-333-96
7500 TABLET, DELAYED RELEASE in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55111-333-01 identifies a specific commercial package of 100 tablet, delayed release in 1 bottle of Pantoprazole, a human prescription drug labeled by Dr.reddy's Laboratories Limited. This tablet, delayed release is formulated for oral use and contains pantoprazole sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr.reddy's Laboratories Limited on January 19, 2011. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this Dr.reddy's Laboratories Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55111033301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55111-333-01
11-Digit CMS (5-4-2)
55111-0333-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.